News
The European Commission has approved EZMEKLY (mirdametinib) for treatment of symptomatic, inoperable plexiform neurofibromas ...
SpringWorks Therapeutics is launching a new disease state education campaign at DesmoidTumors.com. The clinical-stage biotech, which is working on medicines to help patients suffering from rare ...
STAMFORD, Conn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today ...
STAMFORD, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced ...
--SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that it has commenced an underwritten public offering of ...
SpringWorks is committed to improving our understanding of desmoid tumors. There’s a significant need for more education and we are working with urgency and tenacity to help improve the outcomes for ...
Get the latest news on SpringWorks Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on SWTX performance ...
SpringWorks is using Nirogacestat, while AbbVie provides ABBV-383. It is believed that Nirogacestat provides a boost for BCMA therapies like ABBV-383. This isn't the first partnership for SpringWorks.
Springworks’ treatments for adults with desmoid tumors and adults and children with NF1 with symptomatic PN were at the center of the acquisition. The German company agreed to pay $47-per-share of ...
SpringWorks Therapeutics' cash burn of US$37m is about 1.1% of its US$3.5b market capitalisation. So it could almost certainly just borrow a little to fund another year's growth, or else easily ...
About SpringWorks Therapeutics At SpringWorks, a clinical-stage biopharmaceutical company, we are driven to develop life-changing medicines for patients with severe rare diseases and cancer.
Springworks is not an ordinary farm. Founded in 2014 by 19-year-old Trevor Kenkel, Springworks grows lettuce and raises fish in a complex, closed system of circulating water.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results